Advagen metoprolol tartrate tablets recalled for foreign tablets
Advagen Pharma is recalling one batch of metoprolol tartrate tablets, 50 mg, in 1,000-count bottles, because of the presence of foreign tablets or capsules. No injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Talk to your pharmacist or prescriber before stopping this medicine.
- Check whether your bottle has lot 2611C065A1, expiration 05/2028, and NDC 72888-210-00.
- The notice doesn't say how to get a refund or replacement; contact Advagen Pharma or the pharmacy where you filled the prescription.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Metoprolol Tartrate Tablets, USP, 50 mg, 1,000 Tablets per bottle, Rx Only, Distributed by: Advagen Pharma Ltd., East Windsor, NJ 08520, USA. NDC: 72888-210-00.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 3684 bottles
- Illnesses reported
- None reported
- Manufactured in
- 50 Millstone Rd Bldg 200, East Windsor, New Jersey, United States
- Classification
- Class II
- Recall number
- D-0182-2027
In the FDA's words
- Description
- Metoprolol Tartrate Tablets, USP, 50 mg, 1,000 Tablets per bottle, Rx Only, Distributed by: Advagen Pharma Ltd., East Windsor, NJ 08520, USA. NDC: 72888-210-00. Presence of Foreign Tablets/Capsules Batch#: 2611C065A1: Expiry: 05/2028 Distribution: U.S. Nationwide Affected quantity: 3684 bottles
- Hazard
- Presence of Foreign Tablets/Capsules